Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Shiosaki

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|March 28, 1997
Minor structural differences in Boc-CCK-4 derivatives dictate affinity and selectivity for CCK-A and CCK-B receptorsK Shiosaki, C W Lin, H Kopecka, et al.
Psychopharmacology|April 2, 1999
Actions of the D1 agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L-dopa-primed common marmosetsR K Pearce, M Jackson, D R Britton, et al.
Pharmaceutical Research|December 2, 1998
Microencapsulation of hepatitis B core antigen for vaccine preparationT Uchida, K Shiosaki, Y Nakada, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 1, 1997
Expression, release, and regulation of human TNF alpha from stable transfectants of HEK-293 cellsK B Glaser, M Falduto, R Metzger, et al.
Uirusu|June 1, 1987
[Characterization of hepatitis B virus surface antigen produced in yeast]K Sugahara, H Yokote, K Shiosaki, et al.
Gene|March 15, 1989
A novel type of human alpha-amylase produced in lung carcinoid tumorN Tomita, A Horii, S Doi, et al.
Microbiology and Immunology|January 1, 1997
Father-to-mother-to-infant transmission of HIV-1: clonally transmitted isolate of infant mutates more rapidly than that of the mother and rapidly loses reactivity with neutralizing antibodyY Okamoto, K Shiosaki, Y Eda, et al.
Journal of Medicinal Chemistry|September 1, 1995
(5aR,11bS)-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-azacyclopent-1- ena[c]-phenanthrene-9,10-diol (A-86929): a potent and selective dopamine D1 agonist that maintains behavioral efficacy following repeated administration and characterization of its diacetyl prodrug (ABT-431)M R Michaelides, Y Hong, S DiDomenico, et al.
Journal of Medicinal Chemistry|May 23, 1997
Substituted hexahydrobenzo[f]thieno[c]quinolines as dopamine D1-selective agonists: synthesis and biological evaluation in vitro and in vivoM R Michaelides, Y Hong, S DiDomenico, et al.
European Journal of Pharmacology|December 19, 1996
Hyperactivity and behavioral seizures in rodents following treatment with the dopamine D1 receptor agonists A-86929 and ABT-431K Shiosaki, K E Asin, D R Britton, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|March 28, 1997
Minor structural differences in Boc-CCK-4 derivatives dictate affinity and selectivity for CCK-A and CCK-B receptorsK Shiosaki, C W Lin, H Kopecka, et al.
Psychopharmacology|April 2, 1999
Actions of the D1 agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L-dopa-primed common marmosetsR K Pearce, M Jackson, D R Britton, et al.
Pharmaceutical Research|December 2, 1998
Microencapsulation of hepatitis B core antigen for vaccine preparationT Uchida, K Shiosaki, Y Nakada, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 1, 1997
Expression, release, and regulation of human TNF alpha from stable transfectants of HEK-293 cellsK B Glaser, M Falduto, R Metzger, et al.
Uirusu|June 1, 1987
[Characterization of hepatitis B virus surface antigen produced in yeast]K Sugahara, H Yokote, K Shiosaki, et al.
Gene|March 15, 1989
A novel type of human alpha-amylase produced in lung carcinoid tumorN Tomita, A Horii, S Doi, et al.
Microbiology and Immunology|January 1, 1997
Father-to-mother-to-infant transmission of HIV-1: clonally transmitted isolate of infant mutates more rapidly than that of the mother and rapidly loses reactivity with neutralizing antibodyY Okamoto, K Shiosaki, Y Eda, et al.
Journal of Medicinal Chemistry|September 1, 1995
(5aR,11bS)-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-azacyclopent-1- ena[c]-phenanthrene-9,10-diol (A-86929): a potent and selective dopamine D1 agonist that maintains behavioral efficacy following repeated administration and characterization of its diacetyl prodrug (ABT-431)M R Michaelides, Y Hong, S DiDomenico, et al.
Journal of Medicinal Chemistry|May 23, 1997
Substituted hexahydrobenzo[f]thieno[c]quinolines as dopamine D1-selective agonists: synthesis and biological evaluation in vitro and in vivoM R Michaelides, Y Hong, S DiDomenico, et al.
European Journal of Pharmacology|December 19, 1996
Hyperactivity and behavioral seizures in rodents following treatment with the dopamine D1 receptor agonists A-86929 and ABT-431K Shiosaki, K E Asin, D R Britton, et al.
Pageof 4